全部研究成果

 
2024


Liao, ET., Lin, HY., & Tsai, CY. (2024). Updated retinoblastoma incidence and outcome in children in Taiwan from 1980 to 2019: a 40-year nationwide study. Eye. https://doi.org/10.1038/s41433-024-02946-0


2023


Oze I, Ito H, Koyanagi YN, et al. Obesity is associated with biliary tract cancer mortality and incidence: A pooled analysis of 21 cohort studies in the Asia Cohort Consortium. Int J Cancer. 2023. doi: 10.1002/ijc.34794. (IF=6.4, 49/318, Q1)
Yang JJ, Wen W, Zahed H, et al. Lung Cancer Risk Prediction Models for Asian Ever-Smokers. J Thorac Oncol. 2023. doi: 10.1016/j.jtho.2023.11.002. (IF=20.4, 13/241, Q1)
Chang YH, Hsu WL, Lee YK, et al. Trends and sex-specific incidence of upper urinary tract cancer in Taiwan: A birth cohort study. Cancer Med. 2023;12:15350-15357. doi: 10.1002/cam4.6084. (IF=4.0, 96/241, Q2) 
Tsai YS, Chen YC, Chen TI, et al. Incidence trends of oral cavity, oropharyngeal, hypopharyngeal and laryngeal cancers among males in Taiwan, 1980-2019: a population-based cancer registry study..BMC Cancer. 2023;23:213. doi: 10.1186/s12885-023-10651-6. (IF=3.8, 109/241, Q2) 
Chen TI, Lee FJ, Hsu WL, Chen YC*, Chen M. Association of Dipeptidyl Peptidase-4 Inhibitors Use with Reduced Risk of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Chronic HBV Infection. Cancers 2023; 15(4). （共同通訊作者，SCI，IF=5.2, ONCOLOGY: 72/241）
Liu HS, Chen CD, Lee CC, Chen YC*, Cheng WF. Age Specific Risks of Uterine Cancer in Type 2 Diabetes and Associated Comorbidities in Taiwan. Cancers 2022; 14(19). （共同通訊作者，SCI，IF=5.2, ONCOLOGY: 72/241）
Tsai MC, Chou YC, Lee YK, Hsu WL, Tang CS, Chen SY, Huang SP, Chen YC*, Lee JM. Secular Trends in Incidence of Esophageal Cancer in Taiwan from 1985 to 2019: An Age-Period-Cohort Analysis. Cancers 2022; 14(23). （通訊作者，SCI，IF=5.2, ONCOLOGY: 72/241）
Chung CS, Wu CY, Lin YH, Lo WC Cheng PC, Hsu WL, Liao LJ. Screening and Surveillance of Esophageal Cancer by Magnifying Endoscopy with Narrow Band Imaging Improves the Survival of Hypopharyngeal Cancer Patients. Front Oncol (accepted) (非第一或通訊作者，SCI，IF=4.7, Oncology: 85/241)
Lou PJ, Lam WKJ, Hsu WL, Pfeiffer RM, Yu KJ, Chan MLC, Lee CTV, Chen TC, Terng SD, Tsou YA, Leu YS, Liao LJ, Chang YL, Chien YC, Wang CP, Lin CY, Hua CH, Lee JC, Yang TL, Hsiao CH, Wu MS, Tsai MH, Cheng HC, Hildesheim A, Chen CJ, Chan KCA, and Liu Z for the GEV-NPC group. Performance and Operational Feasibility of EBV-based Screening for Detection of Nasopharyngeal Carcinoma: Direct Comparison of Two Alternative Approaches. J Clin Oncol. 2023 Sep 10;41(26):4257-4266 (非第一或通訊作者，SCI，IF=45.4, Oncology: 7/241)
Liao LJ, Hsu WL, Chen CJ, Chiu YL. Feature Reviews of the Molecular Mechanisms of Nasopharyngeal Carcinoma. Biomedicines. 2023 May 25;11(6):1528. (非第一或通訊作者，SCI，IF=4.7, Medicine, Research & Experimental: 54/136)
Schieber J, Pring M, Ness A, Liu Z, Hsu WL, Brenner N, Butt J, Waterboer T, Simon J. Development of a Duplex Serological Multiplex Assay for the Simultaneous Detection of Epstein-Barr Virus IgA and IgG Antibodies in Nasopharyngeal Carcinoma Patients. Cancers (Basel). 2023;15(9):2578. (非第一或通訊作者，SCI，IF=5.2, oncology: 72/241)
Argirion I, Pfeiffer RM, Proietti C, Coghill AE, Yu KJ, Middeldorp JM, Sarathkumara YD, Hsu WL, Chien YC, Lou PJ, Wang CP, Rothman N, Lan Q, Chen CJ, Mbulaiteye SM, Jarrett RF, Glimelius I, Smedby KE, Hjalgrim H, Hildesheim A, Doolan DL, Liu Z. Comparative analysis of the humoral immune response to the EBV proteome across EBV-related malignancies. Cancer Epidemiol Biomarkers Prev. 2023:EPI-22-0452  (非第一或通訊作者，SCI IF=4.090, Public, Environmental & Occupational Health: 60/245)
Lam WKJ, King AD, Miller JA, Liu Z, Yu KJ, Chua MLK, Ma BBY, Chen MY, Pinsky BA, Lou PJ, Woo JKS, Hsu WL, Simon J, Doolan DL, Waterboer T, Hui EP, Li H, Tsang RK, Wong KCW, Goh JP, Vlantis AC, Ai QY, Wong LM, Abdullah V, Lin JC, Chen CJ, Pfeiffer RM, Le QT, Lee AWM, Ji M, Cao S, Ma J, Chan ATC, Chan KCA, Hildesheim A. Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regions. J Natl Cancer Inst. 2023 Apr 11;115(4):355-364. (非第一或通訊作者，SCI，IF=11.816，oncology: 28/241)
Liao LJ, Tung YH, Lin YH, Hsu WL. Application of Real-time Submental Ultrasonography to Assess Swallowing. J Med Ultrasound. 2023 Mar 24;31(4):287-292. (非第一或通訊作者，IF=1.1, Radiology, Nuclear Medicine & Medical Imaging: 170/203)
Lo WC, Cheng PC, Hsu WL, Cheng PW, Liao LJ. A Novel Prediction Model Based on Quantitative Texture Analysis of Sonographic Images for Malignant Major Salivary Glandular Tumors. J Med Ultrasound. 2023 Jan 24;31(3):218-222. (非第一或通訊作者，IF=1.1, Radiology, Nuclear Medicine & Medical Imaging: 170/203)
楊雯雯、吳慧敏、劉嘉玲、鄭國本、余明隆、蒲若芳、盧勝男、簡榮南（2023）。C型肝炎病毒抗體快篩試劑的運用。台灣公共衛生雜誌，42(6)，594-611。https://doi.org/10.6288/TJPH.202312_42(6).112031 (第一或通訊作者)
Wen-Wen Yang, Yi-Chen Juan, Grace Hui-Min Wu, Raoh-Fang Pwu. The Critical Intersect of Regulations, Health Technology Assessment, and Drug Safety Assessments. Drug Saf. 2023 Dec 19. doi: 10.1007/s40264-023-01386-1. (第一或通訊作者，SCIE, IF=4.2, pharmacology & pharmacy: 91/278; public, environmental & occupational health: 72/207)
Chien-Chin Chen, Chyong-Huey Lai, Chih-Long Chang, Wen-Fang Cheng, Raoh-Fang Pwu, Jane Tsai, Peng-Hui Wang, Jacqueline Whang-Peng, Gi-Ming Lai, Managing the transition in cervical screening methods for Taiwan: Policy recommendations and perspectives, Journal of the Formosan Medical Association, 2023, (in press) https://doi.org/10.1016/j.jfma.2023.06.018.
.Oze I, Ito H, Koyanagi YN, et al. Obesity is associated with biliary tract cancer mortality and incidence: A pooled analysis of 21 cohort studies in the Asia Cohort Consortium. Int J Cancer. 2023. doi: 10.1002/ijc.34794. (IF=6.4, 49/318, Q1)
Yang JJ, Wen W, Zahed H, et al. Lung Cancer Risk Prediction Models for Asian Ever-Smokers. J Thorac Oncol. 2023. doi: 10.1016/j.jtho.2023.11.002. (IF=20.4, 13/241, Q1)
 

數據科學中心成員研究成果

數據科學中心成員研究成果

本中心成員研究論文成果

本中心成員研究論文成果

期刊論文

1.     Tsao HM, Shao YJ, Chang YC, Chou YH, Wu VC, Lin SL, et al. Unveiling the Causal Relationship between Thyroid and Kidney Function: A Multivariable Mendelian Randomization. Clin J Am Soc Nephrol. 2025.
2.     Chen YA, Lai TS, Tsao HM, Chen YT. Comparison of outcomes between kidney transplant-naive and post-transplant graft failure peritoneal dialysis patients. J Formos Med Assoc. 2025.
3.     Tsao HM, Lai TS, Chang YC, Hsiung CN, Tsai IJ, Chou YH, et al. A multi-trait GWAS identifies novel genes influencing albuminuria. Nephrol Dial Transplant. 2024;40(1):123–32.
4.     Lai TS, Tsao HM, Chou YH, Liang SL, Chien KL, Chen YM. A competing risk predictive model for kidney failure in patients with advanced chronic kidney disease. J Formos Med Assoc. 2023.
5.     Lin YC, Tsao HM, Lai TS, Chen YT, Chou YH, Lin SL, et al. Effect of Lipid-Lowering Drugs on Renal and Cardiovascular Outcomes in Patients with Chronic Kidney Disease and Dyslipidemia: A Retrospective Cohort Study. Clin Pharmacol Ther. 2023;114(6):1366–74.
6.     Chen YT, Lai TS, Tsao HM, Lai CF, Yang SY, Chen YM. Clinical implications of frailty in peritoneal dialysis patients - A prospective observational study. J Formos Med Assoc. 2023.
7.     Tsao HM, Lai TS, Chou YH, Lin SL, Chen YM. Predialysis trajectories of estimated GFR and concurrent trends of Chronic Kidney Disease-relevant biomarkers. Ther Adv Chronic Dis. 2023;14:20406223231177291.
8.     Tsao HM, Lai TS, Chang YC, Hsiung CN, Chou YH, Wu VC, et al. Serum Urate and Risk of Chronic Kidney Disease: A Mendelian Randomization Study Using Taiwan Biobank. Mayo Clin Proc. 2023;98(4):513–21.
9.     Chang HJ, Hsu YH, Hsueh CW, Pan ML, Tsao HM, Wang DW, et al. Faster in Time and Better in Randomness Algorithms for Matching Subjects with Multiple Controls. International Journal on Advances in Software. 2019;12(3 & 4):249–58.